FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Florian Lordick

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Esophagogastric Junction

Co-author Network

Publications

TOP 3
Florian Lordick; Helena Melezínková; Markus Moehler; Vladimir M Moiseyenko; Sang Cheul Oh; Joon Oh Park; Pamela Salman; Akira Sawaki; Constantin Volovat; György Bodoky; Ilhan Celik; Hyun-Cheol Chung; Vera Gorbunova; Heiko Götte; Yoon-Koo Kang; Galina Kurteva
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
Florian Lordick; C Röcken
The identification of predictive factors for perioperative chemotherapy in esophago-gastric cancer.
Katja Ott; Wilfried Roth; Jörg Rüdiger Siewert; Leila Sisic; Annika Stange; Wilko Weichert; Karen Becker; Susanne Blank; Markus Büchler; Dirk Jäger; Rupert Langer; Florian Lordick
Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Florian Lordick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Florian Lordick; Helena Melezínková; Markus Moehler; Vladimir M Moiseyenko; Sang Cheul Oh; Joon Oh Park; Pamela Salman; Akira Sawaki; Constantin Volovat; György Bodoky; Ilhan Celik; Hyun-Cheol Chung; Vera Gorbunova; Heiko Götte; Yoon-Koo Kang; Galina Kurteva
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
The lancet oncology 2013;14(6):490-9.
2013: Florian Lordick; C Röcken
The identification of predictive factors for perioperative chemotherapy in esophago-gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(5):1135-8.
2013: Katja Ott; Wilfried Roth; Jörg Rüdiger Siewert; Leila Sisic; Annika Stange; Wilko Weichert; Karen Becker; Susanne Blank; Markus Büchler; Dirk Jäger; Rupert Langer; Florian Lordick
Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2013;398(2):239-49.
2013: Florian Lordick; Karen Haustermans; Arnulf H Hölscher; Christian Wittekind
Multimodal treatment of esophageal cancer.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2013;398(2):177-87.
2012: Manfred P Lutz; Christophe Mariette; Markus Moehler; Florian Otto; Tsuneo Oyama; Arnaud Roth; Josef Rueschoff; Thomas Ruhstaller; Raquel Seruca; Michael Stahl; Florian Sterzing; Eric van Cutsem; Ate van der Gaast; Jan van Lanschot; Marc Ychou; John R Zalcberg; Jaffer A Ajani; William Allum; Daniela Aust; Yung-Jue Bang; Stefano Cascinu; Michel Ducreux; Arnulf Hölscher; Janusz Jankowski; Edwin P M Jansen; Ralf Kisslich; Florian Lordick
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2012;48(16):2941-53.
2012: Sylvie Lorenzen; Susanne Blank; Florian Lordick; Jörg Rüdiger Siewert; Katja Ott
Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Annals of surgical oncology 2012;19(7):2119-27.
2012: Florian Lordick
To resect or not resect in metastatic gastric cancer: that is the question!
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2012;15(3):229-31.
2012: Florian Lordick
Gastrointestinal cancer: Salvage chemotherapy in gastric cancer--more than a straw?
Nature reviews. Clinical oncology 2012;9(6):312-3.
2012: Florian Lordick
Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2012;196():201-11.
2012: Nuh N Rahbari; Inga Rossion; Annika Stange; Jürgen Weitz; Ulrich Bork; Markus W Büchler; Stefan Englert; Christine Fink; Dirk Jäger; Meinhard Kieser; Moritz Koch; Florian Lordick; Steffen P Luntz
Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).
BMC cancer 2012;12():142.
2012: Anne Katrin Berger; Stefan Delorme; Georg Martin Haag; Uwe Haberkorn; Matthias Kloor; Florian Lordick; Jennifer Ose; Annika Stange; Carl von Gall; Tim Frederik Weber; Ulrich Abel; Dirk Jäger
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial.
BMC cancer 2012;12():108.
2012: Susanne Blank; Markus Buechler; Lars Grenacher; Florian Lordick; Hendrik Bläker; Anja Schaible; Katja Ott
Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2012;397(1):45-55.
2011: Florian Lordick
The role of PET in predicting response to chemotherapy in oesophago-gastric cancer.
Acta gastro-enterologica Belgica 2011;74(4):530-5.
2011: Katja Ott; Christian Peschel; Tibor Schuster; Markus Schwaiger; Jörg Rüdiger Siewert; Hans-Jürgen Wester; Hinrich A Wieder; Dirk Wilhelm; Christian Meyer zum Büschenfelde; Karen Becker; Andreas K Buck; Matthias P A Ebert; Ken Herrmann; Rupert Langer; Florian Lordick; Bernd Joachim Krause
Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.
Annals of surgical oncology 2011;18(12):3316-23.
2011: Florian Lordick
Current standard and trends in oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S353-4.
2011: Katja Ott; Benjamin Panzram; Sivaramakrishna Rachakonda; Rupert Langer; Florian Lordick; Karen Becker; Markus Buechler; Kari Hemminki; Gisela Keller; Rajiv Kumar
DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Annals of surgical oncology 2011;18(9):2688-98.
2011: Christian Meyer zum Büschenfelde; Karin Becker; Matthias Ebert; Helmut Friess; Hans Geinitz; Ken Herrmann; Rupert Langer; Florian Lordick; Katja Ott; Christian Peschel; Tibor Schuster; Markus Schwaiger; Frank Zimmermann; Bernd Joachim Krause
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1189-96.
2011: Katja Ott; Florian Lordick; Susanne Blank; Markus Büchler
Gastric cancer: surgery in 2011.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2011;396(6):743-58.
2011: Sylvie Lorenzen; Florian Lordick
How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?
Current opinion in oncology 2011;23(4):396-402.
2011: Eric Van Cutsem; C Van de Velde; N Arber; Y Bang; A Benson; A Cervantes; E Diaz-Rubio; Mario Dicato; M Ducreux; R Geva; R Glynne-Jones; A Grothey; D Haller; Karin Haustermans; Y K Kang; D Kerr; Roberto Labianca; Florian Lordick; J Marshall; B Minsky; Bernard Nordlinger; A Ohtsu; N Pavlidis; A Roth; Philippe Rougier; HJ Schmoll; Alberto Sobrero; Josep Tabernero; J Zalcberg
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22 Suppl 5():v1-9.
2011: K Potthoff; Ralf-Dieter Hofheinz; J C Hassel; M Volkenandt; Florian Lordick; Jörg Thomas Hartmann; Meinolf Karthaus; Hanno Riess; H P Lipp; A Hauschild; T Trarbach; A Wollenberg
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(3):524-35.
2011: Florian Lordick
Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancer.
Future oncology (London, England) 2011;7(2):187-99.
2011: Sylvie Lorenzen; Ben Panzram; Gisela Keller; Florian Lordick; Ken Herrmann; Karin Becker; Ruppert Langer; Markus Schwaiger; Jorg Rudiger Siewert; Katja Ott
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(1):178-86.
2011: Sylvie Lorenzen; Ulrich Abel; Jürgen Debus; Georg M Haag; Uwe Haberkorn; Dirk Jäger; Florian Lordick; Annika Stange; Carl von Gall; Wilko Weichert; Jürgen Weitz; Marc W Münter
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
BMC cancer 2011;11():266.
2011: Michael A Ströhlein; Florian Lordick; Dominik Rüttinger; Klaus-Uwe Grützner; Oliver C Schemanski; Michael Jäger; Horst Lindhofer; Michael Hennig; Karl-Walter Jauch; Christian Peschel; Markus M Heiss
Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial.
Onkologie 2011;34(3):101-8.
2010: Christoph Schuhmacher; Stephan Gretschel; Florian Lordick; Peter Reichardt; Werner Hohenberger; Claus F Eisenberger; Cornelie Haag; Murielle E Mauer; Baktiar Hasan; John Welch; Katja Ott; Arnulf H Hoelscher; Paul M Schneider; Wolf Bechstein; Hans Wilke; Manfred P Lutz; Bernard Nordlinger; Eric Van Cutsem; Jörg R Siewert; Peter M Schlag
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(35):5210-8.
2010: Stephan Metz; Carl Ganter; Sylvie Lorenzen; Sandra van Marwick; Ken Herrmann; Florian Lordick; Stephan Nekolla; Ernst J Rummeny; Hans-Jürgen Wester; Gunnar Brix; Markus Schwaiger; Ambros J Beer
Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(11):1691-8.
2010: Marc Peeters; Timothy Jay Price; Andrés Cervantes; Alberto F Sobrero; Michel Ducreux; Yevhen Hotko; Thierry André; Emily Chan; Florian Lordick; Cornelis J A Punt; Andrew H Strickland; Gregory Wilson; Tudor-Eliade Ciuleanu; Laslo Roman; Eric Van Cutsem; Valentina Tzekova; Simon Collins; Kelly S Oliner; Alan Rong; Jennifer Gansert
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4706-13.
2010: Rupert Langer; Katja Ott; Marcus Feith; Florian Lordick; Katja Specht; Karen Becker; Heinz Hofler
High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients.
Journal of surgical oncology 2010;102(5):503-8.
2010: Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu; Yasushi Omuro; Taroh Satoh; Giuseppe Aprile; Evgeny Kulikov; Julie Hill; Michaela Lehle; Josef Rüschoff; Yoon-Koo Kang
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet 2010;376(9742):687-97.
2010: Jan Friederichs; Claus W H von Weyhern; Robert Rosenberg; dietrich doll; Raymonde Busch; Florian Lordick; Jörg Rüdiger Siewert; Mario Sarbia
Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2010;395(4):373-9.
2010: Florian Lordick; Birgit Luber; Sylvie Lorenzen; S Hegewisch-Becker; G Folprecht; E Wöll; T Decker; Esther Endlicher; N Röthling; T Schuster; Gisela Keller; Falko Fend; Christian Peschel
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
British journal of cancer 2010;102(3):500-5.
2010: Ralf-Dieter Hofheinz; Salah-Eddin Al-Batran; Karsten Ridwelski; Christian Görg; Klaus Wehle; Matthias Birth; Sebastian Fetscher; Harald Scheiber; Nadine Lukan; Florian Lordick
Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany.
Onkologie 2010;33(10):512-8.
2010: Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
The lancet oncology 2010;11(1):38-47.
2009: Gertraud Stocker; Katja Ott; Nils Henningsen; Karen Becker; Alexander Hapfelmeier; Florian Lordick; Stefan Hois; Susanne Plaschke; Heinz Höfler; Gisela Keller
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3326-35.
2009: Rupert Langer; Katja Ott; Marcus Feith; Florian Lordick; Jörg Rüdiger Siewert; Karen Becker
Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(12):1555-63.
2009: Sylvie Lorenzen; T Schuster; R Porschen; S-E Al-Batran; Ralf-Dieter Hofheinz; P Thuss-Patience; M Moehler; P Grabowski; D Arnold; Tim F Greten; L Müller; N Röthling; Christian Peschel; Rupert Langer; Florian Lordick
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(10):1667-73.
2009: Brian G Czito; Florian Lordick
Accomplishments in 2008 in the adjuvant treatment of rectal cancer.
Gastrointestinal cancer research : GCR 2009;3(5 Supplement 2):S8-S14.
2009: Anne Katrin Berger; Frauke Bellos; Annika Siegmund; Christoph Eisenbach; Florian Lordick
Symptomatic hyponatraemia caused by cylophosphamide.
Onkologie 2009;32(5):280-2.
2009: Katja Ott; Franz G Bader; Florian Lordick; Marcus Feith; Holger Bartels; J Ruediger Siewert
Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
Annals of surgical oncology 2009;16(4):1017-25.
2009: Katja Ott; Florian Lordick; Michael Molls; Holger Bartels; Edgar Biemer; Jörg Rüdiger Siewert
Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus.
The British journal of surgery 2009;96(3):258-66.
2009: Florian Lordick
[Multidisciplinary treatment for adult soft tissue sarcoma].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2009;80(3):209-15.
2009: Anthony J Cmelak; Florian Lordick; Markus Borner; Richard M Goldberg; M Wasif Saif
Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.
Oncology (Williston Park, N.Y.) 2009;23(2 Suppl 1):18-25.
2009: Leonidas Apostolidis; Christoph Kahlert; Annika Siegmund; Rabea Thom; Solveig Horstmann; Dirk Jäger; Florian Lordick
Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib.
Onkologie 2009;32(1-2):50-3.
2009: Kathrin Abbrederis; Sylvie Lorenzen; Nadine Rothling; Angela Ihbe-Heffinger; Tibor Schuster; Christian Peschel; Florian Lordick
Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
Onkologie 2009;32(1-2):30-4.
2009: Robert Rosenberg; Ken Herrmann; Ralf Gertler; Beat Künzli; Markus Essler; Florian Lordick; Karen Becker; Tibor Schuster; Hans Geinitz; Matthias Maak; M Schwaiger; Jörg Rüdiger Siewert; Bernd Krause
The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT.
International journal of colorectal disease 2009;24(2):191-200.
2008: Matthias Schauer; Hubert Stein; Florian Lordick; Marcus Feith; Jörg Theisen; Joerg-Ruediger Siewert
Results of a multimodal therapy in patients with stage IV Barrett's adenocarcinoma.
World journal of surgery 2008;32(12):2655-60.
2008: Katja Ott; Ken Herrmann; Bernd-Joachim Krause; Florian Lordick
The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.
Gastrointestinal cancer research : GCR 2008;2(6):287-94.
2008: Sylvie Lorenzen; Björn L.D.M. Brücher; Frank B Zimmermann; Hans Geinitz; J Riera; T Schuster; N Roethling; Heinz Höfler; Katja Ott; Christian Peschel; Jörg Rüdiger Siewert; Michael Molls; Florian Lordick
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial.
British journal of cancer 2008;99(7):1020-6.
2008: W Hartwig; W Hartung; Oliver Strobel; Florian Lordick; Markus W Büchler; Jens Werner
[Multimodal therapy of esophageal cancer].
Zeitschrift für Gastroenterologie 2008;46(10):1207-13.
2008: Florian Lordick; J Krauss; D Jäger
[Tumor markers and biomarkers in squamous cell cancer of the head and neck].
HNO 2008;56(9):881-5.
2008: Florian Lordick; Katja Ott; Jürgen Weitz; Dirk Jäger
The evolving role of catumaxomab in gastric cancer.
Expert opinion on biological therapy 2008;8(9):1407-15.
2008: Florian Lordick; Theo Ruers; Daniela E Aust; Laurence Collette; Robert J Downey; Mostafa El Hajjam; Patrick Flamen; Karen Haustermans; David H Ilson; Catherine Julié; Bernd Joachim Krause; Hartwig Newiger; Katja Ott; Arnaud Roth; Eric Van Cutsem; Wolfgang A Weber; Manfred P Lutz
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.
European journal of cancer (Oxford, England : 1990) 2008;44(13):1807-19.
2008: Katja Ott; Florian Lordick; Karen Becker; Kurt Ulm; JörgRüdiger Siewert; Heinz Höfler; Gisela Keller
Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.
International journal of colorectal disease 2008;23(8):773-82.
2008: Florian Lordick; Dirk Jäger
Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers.
Gastrointestinal cancer research : GCR 2008;2(4):187-97.
2008: Franz G Bader; Florian Lordick; Ulrich Fink; Karen Becker; Heinz Hofler; Raymonde Busch; Jorg R Siewert; Katja Ott
Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up.
Onkologie 2008;31(7):366-72.
2008: U Heger; Jürgen Weitz; Florian Lordick
[Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2008;79(7):630-7.
2008: Katja Ott; Ken Herrmann; Florian Lordick; Hinrich A Wieder; Wolfgang A Weber; Karen Becker; Andreas K Buck; Martin Dobritz; Ulrich Fink; Kurt Ulm; Tibor Schuster; Markus Schwaiger; Jörg Rüdiger Siewert; Bernd J Krause
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2012-8.
2008: K Abbrederis; Sylvie Lorenzen; L Fischer von Weikersthal; Ursula Vehling-Kaiser; T Schuster; N Rothling; Christian Peschel; Florian Lordick
Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status.
Critical reviews in oncology/hematology 2008;66(1):84-90.
2008: Florian Lordick; Jörg Rüdiger Siewert
[Bevacizumab (Avastin) related surgical complications: comment to Abbrederis K et al. (2007)].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2008;79(4):356-60.
2008: Claus Rödel; Dirk Arnold; Matthias Hipp; Torsten Liersch; Kathrin Dellas; Igors Iesalnieks; Robert Michael Hermann; Florian Lordick; Axel Hinke; Werner Hohenberger; Rolf Sauer
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.
International journal of radiation oncology, biology, physics 2008;70(4):1081-6.
2008: Stefan Boeck; T Hoehler; G Seipelt; R Mahlberg; A Wein; A Hochhaus; H-P Boeck; B Schmid; Erika Kettner; M Stauch; Florian Lordick; Y Ko; M Geissler; Konrad Schoppmeyer; G Kojouharoff; A Golf; S Neugebauer; Volker Heinemann
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):340-7.
2008: Katja Ott; Florian Lordick; Ken Herrmann; Bernd-Joachim Krause; Christoph Schuhmacher; Jörg Rüdiger Siewert
The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2008;11(1):1-9.
2008: Eric Van Cutsem; Cornelius Van de Velde; A Roth; Florian Lordick; Claus-Henning Köhne; Stefano Cascinu; Matti Aapro
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
European journal of cancer (Oxford, England : 1990) 2008;44(2):182-94.
2008: Ambros J Beer; Sylvie Lorenzen; Stephan Metz; Ken Herrmann; Petra Watzlowik; Hans-Jürgen Wester; Christian Peschel; Florian Lordick; Markus Schwaiger
Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(1):22-9.
2008: Hinrich A Wieder; Alexander Stahl; Florian Lordick; Katja Ott
Esophageal cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2008;170():71-9.
2007: Ken Herrmann; Katja Ott; Andreas K Buck; Florian Lordick; Dirk Wilhelm; Michael Souvatzoglou; Karen Becker; Tibor Schuster; Hans-Jürgen Wester; Jörg R Siewert; Markus Schwaiger; Bernd J Krause
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(12):1945-50.
2007: Hinrich A Wieder; Katja Ott; Florian Lordick; Karen Becker; Alexander Stahl; Ken Herrmann; Ulrich Fink; Jörg Rüdiger Siewert; Markus Schwaiger; Wolfgang A Weber
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.
European journal of nuclear medicine and molecular imaging 2007;34(12):1925-32.
2007: Joerg R Siewert; Florian Lordick; Katja Ott; Hubert J Stein; Wolfgang A Weber; Karen Becker; Christian Peschel; Ulrich Fink; Markus Schwaiger
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Annals of surgery 2007;246(4):624-8; discussion 628-31.
2007: Sylvie Lorenzen; Marcus Hentrich; C Haberl; Volker Heinemann; T Schuster; T Seroneit; N Roethling; Christian Peschel; Florian Lordick
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1673-9.
2007: Rudolf Napieralski; Katja Ott; Markus Kremer; Karen Becker; Anne-Laure Boulesteix; Florian Lordick; Jörg Rüdiger Siewert; Heinz Höfler; Gisela Keller
Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular features.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):5095-102.
2007: Florian Lordick; Katja Ott; Bernd J Krause; Wolfgang A Weber; Karen Becker; Hubert J Stein; Sylvie Lorenzen; Tibor Schuster; Hinrich A Wieder; Ken Herrmann; Rainer Bredenkamp; Heinz Höfler; Ulrich Fink; Christian Peschel; Markus Schwaiger; Jörg R Siewert
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
The lancet oncology 2007;8(9):797-805.
2007: Rupert Langer; Katja Specht; Karen Becker; Philipp Ewald; Katja Ott; Florian Lordick; Jörg Rüdiger Siewert; Heinz Höfler
Comparison of pretherapeutic and posttherapeutic expression levels of chemotherapy-associated genes in adenocarcinomas of the esophagus treated by 5-fluorouracil- and cisplatin-based neoadjuvant chemotherapy.
American journal of clinical pathology 2007;128(2):191-7.
2007: Hinrich A Wieder; Robert Rosenberg; Florian Lordick; Hans Geinitz; Ambros J Beer; Karen Becker; Klaus Woertler; Martin Dobritz; Jörg R Siewert; Ernst J Rummeny; Jens Stollfuss
Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
Radiology 2007;243(3):744-51.
2007: Hinrich A Wieder; Hans Geinitz; Robert Rosenberg; Florian Lordick; Karen Becker; Alexander Stahl; Ernst J Rummeny; Jörg R Siewert; Markus Schwaiger; Jens Stollfuss
PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.
European journal of nuclear medicine and molecular imaging 2007;34(6):878-83.
2007: Christoph Schuhmacher; Florian Lordick; R Bumm; J Tepe; Jörg Rüdiger Siewert
["Good advice is precious." The second opinion from the point of view of an interdisciplinary cancer therapy center].
Deutsche medizinische Wochenschrift (1946) 2007;132(17):921-6.
2007: Stefan Boeck; K Weigang-Köhler; M Fuchs; Erika Kettner; Detlef Quietzsch; J Trojan; O Stötzer; S Zeuzem; Florian Lordick; Claus-Henning Köhne; H Kröning; T Steinmetz; H Depenbrock; Volker Heinemann
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):745-51.
2007: Harald Gündel; Verena Hümmeler; Florian Lordick
[Which tumor patients profit from interdisciplinary psychoeducation in the framework of a tumor therapy?].
Zeitschrift für Psychosomatische Medizin und Psychotherapie 2007;53(4):324-38.
2007: Sylvie Lorenzen; Ken Herrmann; Wolfgang A Weber; Hinrich A Wieder; M Hennig; Katja Ott; Rainer Bredenkamp; Christian Peschel; Markus Schwaiger; Florian Lordick
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Nuklearmedizin. Nuclear medicine 2007;46(6):263-70.
2007: Claus Rödel; Torsten Liersch; Robert Michael Hermann; Dirk Arnold; Thomas Reese; Matthias Hipp; Alois Fürst; Nimrod Schwella; Michael Bieker; Gunter Hellmich; Hermann Ewald; Jörg Haier; Florian Lordick; Michael Flentje; Heiko Sülberg; Werner Hohenberger; Rolf Sauer
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):110-7.
2007: Florian Lordick; Birgit Ehlken; Angela Ihbe-Heffinger; Karin Berger; Karl J Krobot; James Pellissier; Glenn Davies; Robert Deuson
Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.
European journal of cancer (Oxford, England : 1990) 2007;43(2):299-307.
2006: Katja Ott; Holger Vogelsang; Noemi Marton; Karen Becker; Florian Lordick; Michael Kobl; Christoph Schuhmacher; Alexander R Novotny; James Mueller; Ulrich Fink; Kurt Ulm; Jörg Rüdiger Siewert; Heinz Höfler; Gisela Keller
The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancer.
International journal of cancer. Journal international du cancer 2006;119(12):2885-94.
2006: Florian Lordick; Matthias Ebert; Hubert J Stein
Current treatment approach to locally advanced esophageal cancer: is resection mandatory?
Future oncology (London, England) 2006;2(6):717-21.
2006: R Witzig; B Schönberger; U Fink; R Busch; H Gundel; Andreas Sendler; C Peschel; J R Siewert; Florian Lordick
Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma.
Endoscopy 2006;38(11):1122-6.
2006: Katja Ott; Wolfgang A Weber; Florian Lordick; Karen Becker; Raymonde Busch; Ken Herrmann; Hinrich A Wieder; Ulrich Fink; Markus Schwaiger; Jörg Rüdiger Siewert
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4692-8.
2006: Kathrin Abbrederis; Florian Bassermann; Christoph Schuhmacher; Verena Voelter; Raymonde Busch; Nadine Roethling; Andreas Sendler; Joerg R Siewert; Christian Peschel; Florian Lordick
Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
The Annals of thoracic surgery 2006;82(1):293-7.
2006: Björn L.D.M. Brücher; Karen Becker; Florian Lordick; Ulrich Fink; Mario Sarbia; Hubert Stein; Raymonde Busch; Frank Zimmermann; Michael Molls; Heinz Höfler; Jörg R Siewert
The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
Cancer 2006;106(10):2119-27.
2006: Ambros J Beer; Hinrich A Wieder; Florian Lordick; Katja Ott; Michael Fischer; Karen Becker; Jens Stollfuss; Ernst J Rummeny
Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy.
Radiology 2006;239(2):472-80.
2006: Florian Lordick; Hans Geinitz; Joerg Theisen; Andreas Sendler; Mario Sarbia
Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases.
International journal of radiation oncology, biology, physics 2006;64(5):1295-8.
2005: Hinrich A Wieder; Ambros J Beer; Florian Lordick; Katja Ott; Michael Fischer; Ernst J Rummeny; Sibylle Ziegler; Jörg R Siewer; Markus Schwaiger; Wolfgang A Weber
Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2029-34.
2005: Howard Hochster; Erika Kettner; Hendrik Kroning; Klaus Becker; Florian Lordick; Ramesh K Ramanathan; John Macdonald; Shengyan Hong; William John; Hans-Joachim Schmoll
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer.
Clinical colorectal cancer 2005;5(4):257-62.
2005: Florian Lordick; Sylvie Lorenzen; Jens Stollfuss; Ursula Vehling-Kaiser; Frank Kullmann; Marcus Hentrich; R Zumschlinge; H Dietzfelbinger; J Thoedtmann; M Hennig; T Seroneit; Rainer Bredenkamp; J Duyster; Christian Peschel
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.
British journal of cancer 2005;93(2):190-4.
2005: Sylvie Lorenzen; J Duyster; Christian Lersch; Stefan von Delius; M Hennig; Rainer Bredenkamp; Christian Peschel; Florian Lordick
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial.
British journal of cancer 2005;92(12):2129-33.
2005: Rudolf Napieralski; Katja Ott; Markus Kremer; Katja Specht; Holger Vogelsang; Karen Becker; Martina Müller; Florian Lordick; Ulrich Fink; Jörg Rüdiger Siewert; Heinz Höfler; Gisela Keller
Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):3025-31.
2005: Florian Lordick; Angela Ihbe-Heffinger; Christian Peschel
[Antiemetic prophylaxis in the chemotherapy of gastrointestinal tumours].
Zeitschrift für Gastroenterologie 2005;43(4):391-8.
2005: Florian Lordick; Christian Peschel; Jörg Rüdiger Siewert
Antibody-based targeted therapy for gastric cancer.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2005;8(4):206-8.
2005: Florian Lordick; J Rüdiger Siewert
Recent advances in multimodal treatment for gastric cancer: a review.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2005;8(2):78-85.
2004: Verena Voelter; Christoph Schuhmacher; Raymonde Busch; Christian Peschel; Jörg Rüdiger Siewert; Florian Lordick
Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer.
The Annals of thoracic surgery 2004;78(3):1037-41.
2004: Alexander Stahl; Hinrich A Wieder; Hans-Jürgen Wester; Morand Piert; Florian Lordick; Katja Ott; Ernst J Rummeny; Markus Schwaiger; Wolfgang A Weber
PET/CT molecular imaging in abdominal oncology.
Abdominal imaging 2004;29(3):388-97.
2004: Florian Lordick; Hubert J Stein; C Peschel; Jörg Rüdiger Siewert
Neoadjuvant therapy for oesophagogastric cancer.
The British journal of surgery 2004;91(5):540-51.
2004: Angela Ihbe-Heffinger; Birgit Ehlken; R Bernard; Karin Berger; Christian Peschel; H-G Eichler; Robert Deuson; J Thödtmann; Florian Lordick
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):526-36.
2004: Hinrich A Wieder; Björn L.D.M. Brücher; Frank Zimmermann; Karen Becker; Florian Lordick; Ambros J Beer; Markus Schwaiger; Ulrich Fink; Jörg Rüdiger Siewert; Hubert J Stein; Wolfgang A Weber
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):900-8.
2003: Katja Ott; Ulrich Fink; Karen Becker; Alexander Stahl; Hans-Joachim Dittler; Raymonde Busch; Hubert Stein; Florian Lordick; Thomas Link; Markus Schwaiger; Jörg Rüdiger Siewert; Wolfgang A Weber
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4604-10.
2003: Florian Lordick; Christoph von Schilling; H Bernhard; M Hennig; Rainer Bredenkamp; Christian Peschel
Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer.
British journal of cancer 2003;89(4):630-3.
2003: Florian Lordick; Marcus Hentrich; Thomas Decker; Michael Hennig; Hans Pohlmann; Reiner Hartenstein; Christian Peschel
Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study.
British journal of haematology 2003;120(6):1073-8.
2003: Harald Gündel; Florian Lordick; Tobias Brandl; Florian Würschmidt; Jutta Schüssler; Birgit Leps; Andreas Sendler; Erdal Mert; Doris Pouget-Schors; Christoph von Schilling; Christian Peschel; Almuth Sellschopp
[Interdisciplinary psychoeducational intervention by oncologists proved helpful for cancer patients].
Zeitschrift für Psychosomatische Medizin und Psychotherapie 2003;49(3):246-61.
2002: Florian Lordick; Harald Gündel; Christoph von Schilling; Florian Würschmidt; Birgit Leps; Andreas Sendler; Jutta Schüssler; Tobias Brandl; Christian Peschel; Almuth Sellschopp
[Structured patient education in oncology. A prospective study for implementing and effectiveness of interdisciplinary psycho-educational group intervention at a German university clinic].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(8):449-54.